Community-associated MRSA in the United Kingdom

Journal of Infection

Volumn 59, Issue 3, 2009, Pages 149-155

  Elston, J W T ^a   Barlow, G D ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Clinical impact; Community associated; Epidemiology; MRSA; UK

Indexed keywords

BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; CLINDAMYCIN; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FUSIDATE SODIUM; FUSIDIC ACID; GENTAMICIN; LINEZOLID; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIGECYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; CLINICAL PROTOCOL; COMMUNICABLE DISEASE; EPIDEMIC; HIGH RISK POPULATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; LOADING DRUG DOSE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; REVIEW; RISK FACTOR; TREATMENT INDICATION; UNITED KINGDOM;

COMMUNITY-ACQUIRED INFECTIONS; GREAT BRITAIN; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 69749113324     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.07.001     Document Type: Review

References (45)

1. Jevons M.P. 'Celbenin'-resistant staphylococci. Br Med J 1 (1961) 124-125
2. Voss A., Milatovic D., Wallrauch-Shwarz C., Rosdahl V.T., and Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 13 (1994) 50-55
3. Zetola N., Francis J.S., Nuermberger E.L., and Bishai W.R. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 5 (2005) 275-286
4. Vandenesch F., Naimi T., Enright M.C., Lina G., Nimmo G.R., Heffernan H., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9 (2003) 978-984
5. Fridkin S.K., Hageman J.C., Morrison M., Sanza L., Como-Sabetti K., Jernigan J.A., et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352 (2005) 1436-1444
6. Francis J.S., Doherty M.C., Lopatin U., Johnston C.P., Sinha G., Ross T., et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 40 (2005) 100-107
7. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., et al. Methicillin-resistant Staphylococcus aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
8. Frazee B.W., Lynn J., Charlebois E.D., Lambert L., Lowery D., and Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med 45 (2005) 311-320
9. King M.D., Humprey B.J., Wang Y.F., Kourbatova E.V., Ray S.M., and Blumberg H.M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA300 clone as the predominant cause of skin and soft tissue infections. Ann Intern Med 144 (2006) 309-317
10. Otter J.A., and French G.L. Nosocomial transmission of community-associated methicillin resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 6 (2006) 753-755
11. Robinson A.D., Kearns A.M., Holmes A., Morrison D., Grundmann H., Edwards G., et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 365 (2005) 1256-1258
12. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., et al. Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
13. Naas T., Fortineau N., Spicq C., Robert J., Jarlier V., and Nordmann P. Three-year survey of community-acquired methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a French university hospital. J Hosp Infect 61 (2005) 321-329
14. David M.Z., Glikman D., Crawford S.E., Peng J., King K.J., Hostelter M.A., et al. What is community-associated methicillin-resistant Staphylococcus aureus?. J Infect Dis 197 (2008) 1235-1243
15. Okuma K., Iakawa K., Turnidge J.D., Grubb W.B., Bell J.M., O'Brien F.G., et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40 (2002) 4289-4294
16. Diederen B.M.W., and Kluytmans J.A.J.W. The emergence of infections with community-associated methicillin-resistant Staphylococcus aureus. J Infect 52 (2006) 157-168
17. Donnio P.Y., Preney L., Gautier-Lerestif A.L., Avril J.L., and LAfforgue N. Changes in staphylococcal cassette chromosome type and antibiotic resistance profile in methicillin-resistant Staphylococcus aureus isolates from a French hospital over an 11 year period. J Antimicrob Chemother 52 (2004) 808-813
18. Rollason J., Bastin L., Hilton A.C., Pillay D.G., Worthington T., McKeon C., et al. Epidemiology of community-acquired meticillin-resistant Staphylococcus aureus obtained from the UK West Midlands region. J Hosp Infect 70 (2008) 314-320
19. Lina G., Piemont Y., Godail-Gamot F., Bes M., Vandernesch F., and Etienne J. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29 (1999) 1128-1132
20. Centers for Disease Control and Prevention. CA-MRSA infections - Michigan. MMWR Morb Mortal Wkly Rep 52 (1981) 793-795
21. Salgado C.D., Farr B.M., and Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36 (2003) 131-139
22. Folden D.V., Machayya J.A., Sahmoun A.E., Beal J.R., Holzman G.S., Helgerson S.D., et al. Estimating the proportion of community-associated methicillin-resistant Staphylococcus aureus: two definitions yield dramatically different estimates. J Hosp Infect 60 (2005) 329-332
23. Health Protection Agency. Community MRSA in England and Wales: definition through strain characterization. Commun Dis Rep Wkly 15 11 (2005) 3-4
24. Millar B.C., Loughrey A., Elborn J.S., and Moore J.E. Proposed definitions of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 67 (2007) 109-113
25. Kearns A.M., Rathmann I.M., Holmes A., Pitt T.L., and Cookson B.D. An unusual clone of MRSA causing injection drug user-related sepsis. J Infect 49 (2004) 49-50
26. Holmes A., Ganner M., McGuane S., Pitt T.L., Cookson B.D., and Kearns A.M. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease. J Clin Microbiol 43 5 (2005) 2384-2390
27. Reichert B., Birrell G., and Bignardi G. Severe non-pneumonic necrotizing infections in children caused by Panton-Valentine leukocidin producing Staphylococcus aureus strains. J Infect 50 (2005) 438-442
28. Jeyaratnam D., Reid C., Kearns A., and Klein J. Community associated MRSA: an alert to paediatricians. Arch Dis Child 91 (2006) 511-512
29. Hampson F.G., Hancock S.W., and Primhak R.A. Disseminated sepsis due to a Panton-Valentine leukocidin producing strain of community-acquired methicillin-resistant Staphylococcus aureus and use of intravenous immunoglobulin therapy. Arch Dis Child 91 (2006) 201-203
30. Loughrey A., Cherie Millar B., Goldsmith C.E., Rooney P.J., and Moore J.E. Emergence of community-associated MRSA (CA-MRSA) in Northern Ireland. Ulster Med J 76 2 (2007) 68-71
31. David M.D., Kearns A.M., Gossain S., Ganner M., and Holmes A. Community-associated methicillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. J Hosp Infect 64 (2006) 244-250
32. Health Protection Agency. Hospital-associated transmission of Panton-Valentine leukocidin (PVL) positive community associated MRSA in the West Midlands. Commun Dis Rep Wkly 16 50 (2006) 1-2
33. Seetulsingh P., Curtis C., and Kearns A.M. Outbreak of ciprofloxacin-susceptible community associated methicillin resistant Staphylococcus aureus in a neonatal unit. J Hosp Infect 68 (2008) 374-375
34. Gould I.M., Girvan E.K., Browning R.A., Mackenzie F.M., and Edwards G.F.S. Report of a hospital outbreak of community-associated methicillin-resistant Staphylococcus aureus. Epidemiol Infect (2009) 1-7 [Epub]
35. Kearns A.M., Ganner M., Hill R.L.R., East C., McCormick Smith I., Ganner M.A., et al. Community-associated MRSA ST8-SCCmecIVa (USA-300): experience in England and Wales. Clin Microbiol Infect 13 Suppl. 1 (2007) S27
36. Otter J.A., and French G.L. The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000-2006. Clin Microbiol Infect 14 (2008) 670-676
37. Elston JWT, Meigh J, Kearns AM, Jordan-Owers N, Newton A, Meigh RE, et al. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology, microbiology and clinical impact in East Yorkshire, UK. J Hosp Infect; in press.
38. Tristan A., Bes M., Meugnier H., Lina G., Bozdogan B., Courvalin P., et al. Global distribution of Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 13 (2007) 594-600
39. Miller L.G., Perdreau-Remington F., Bayer A.S., Diep B., Tan N., Bharadwa K., et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus from methicillin susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 44 (2007) 471-482
40. Nathwani D., Morgan M., Masterton R.G., Dryden M., Cookson B.D., French G.L., et al. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 61 5 (2008) 976-994
41. Health Protection Agency. Guidance on the diagnosis and management of PVL-associated Staphylococcus aureus infections (PVL-SA) in England. 2008.
42. Al-Tawfiq J.A. Father-to-infant transmission of community-acquired methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 27 (2006) 636-637
43. Urth T., Juul G., Skov R., and Schønheyder H.C. Spread of a methicillin-resistant Staphylococcus aureus ST80-IV clone in a Danish community. Infect Control Hosp Epidemiol 26 (2005) 144-149
44. Hill R, Kearns AM, Pike R, Holmes A, Ganner M, McCormick Smith I, et al. Comparative antibiotic susceptibilities of diverse lineages of community-associated MRSA in England and Wales. Health Protection Agency. Poster presentation, 12th International Symposium on Staphylococci and Staphylococcal Infections (ISSSI), Maastricht, The Netherlands, September 2006.
45. O'Brien F.G., Zaini Z., Coombs G.W., Pearson J.C., Christiansen K., and Grubb W.B. Macrolide, lincosamide and streptogramin B resistance in a dominant clone of Australian community methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 56 5 (2005) 985-986